Home treatment for cancer patients using their own stem cells
Home-based Autologous Hematopoietic Stem Cell Transplantation to ImproveOutcomes and Decrease Costs
['FUNDING_R01'] · UNIVERSITY OF KANSAS MEDICAL CENTER · NIH-11251676
This study is exploring a new way for older cancer patients to get stem cell treatment at home instead of in a hospital, with daily visits from healthcare providers to offer personalized support and make the experience easier for both patients and their caregivers.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KANSAS MEDICAL CENTER (nih funded) |
| Locations | 1 site (KANSAS CITY, UNITED STATES) |
| Trial ID | NIH-11251676 on ClinicalTrials.gov |
What this research studies
This research investigates a new approach to autologous hematopoietic stem cell transplantation (HCT) that allows older cancer patients to receive treatment at home instead of in a hospital. By providing intensive support and individualized care management, the study aims to help patients and their caregivers manage the complexities of HCT in a more comfortable environment. The approach includes daily house calls from healthcare providers who work closely with patients and caregivers to create tailored treatment plans, potentially improving quality of life and reducing caregiver strain.
Who could benefit from this research
Good fit: Ideal candidates for this research are older cancer patients who are eligible for autologous hematopoietic stem cell transplantation.
Not a fit: Patients who are not undergoing autologous hematopoietic stem cell transplantation or those who require intensive hospital-based care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life for cancer patients and their caregivers while reducing healthcare costs.
How similar studies have performed: Previous pilot studies have shown promising results for home-based HCT, indicating that this approach may be effective and beneficial for patients.
Where this research is happening
KANSAS CITY, UNITED STATES
- UNIVERSITY OF KANSAS MEDICAL CENTER — KANSAS CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SUNG, ANTHONY — UNIVERSITY OF KANSAS MEDICAL CENTER
- Study coordinator: SUNG, ANTHONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.